{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-022025-04-021111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-022025-04-021111100
Download SVG
Download PNG
Download CSV

ubs maintains buy rating for reckitt benckiser with target price of 7700 pence

UBS has maintained its "Buy" rating for Reckitt Benckiser, setting a target price of 7700 pence. Analyst Guillaume Delmas anticipates a solid start to the year for the consumer goods group, projecting organic sales growth of 1.2 percent, slightly below the consensus of 1.6 percent, with core business growth expected at 2.5 percent.

ubs maintains buy rating for reckitt benckiser with target price of 7700 pence

UBS has maintained its "Buy" rating for Reckitt Benckiser, setting a target price of 7700 pence. Analyst Guillaume Delmas noted that 53% of Reckitt's US sales are generated from local production, positioning the company well to navigate new US tariffs compared to other European consumer goods firms.

Reckitt Benckiser's diverse product portfolio drives global sales growth

Reckitt Benckiser Group plc specializes in household cleaning, personal care, and OTC remedies, with net sales divided into household hygiene (42%), OTC and health products (41.5%), and nutrition (16.5%). Geographically, sales are distributed with 6.1% in the UK, 31.1% in the US, and 62.8% in other regions. Key brands include Dettol, Lysol, Gaviscon, and Enfamil.

ubs highlights key investment opportunities in europe for 2025

UBS identifies Adyen, Aryzta, and Moonpig Group as top European stock picks for 2025, highlighting growth potential amid economic challenges. The European economy is expected to grow by 0.9% with inflation easing to 2.1%, while the European Central Bank may cut rates to 2% by mid-2025. Despite a projected 5% earnings decline in 2025 due to margin pressures, selective fiscal policies in the UK and EU aim to support green initiatives and digital transformation.

global pediatric healthcare market poised for significant growth through 2032

The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.

global consumer health market projected to reach over 713 billion by 2033

The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.

buyout firms explore acquisition of reckitt's homecare assets valued at £6 billion

Advent International and Apollo Global Management Inc. are among several buyout firms exploring a potential acquisition of Reckitt Benckiser Group Plc’s homecare assets, valued at over £6 billion. Other interested parties include Clayton Dubilier & Rice and PAI Partners, though some suitors believe the valuation should be lower. Reckitt has circulated teasers outlining the business to potential buyers.

global hospital acquired infection control market poised for significant growth

The global Hospital Acquired Infection Control (HAIC) market is projected to grow at a CAGR of about 4% from 2021 to 2027, driven by advancements in sterilization technology and rising awareness of hygiene. The protective barrier segment leads the market, fueled by increasing infection rates and a growing elderly population. North America holds a significant market share, supported by government initiatives and investments in healthcare infrastructure.

ubs raises price targets for lloyds and hochschild mining stocks

UBS has raised its target price for Lloyds to 63p, maintaining a 'neutral' rating, while also increasing Hochschild Mining's target to 290p with a 'buy' recommendation. Additionally, RBC and Deutsche Bank have raised target prices for Reckitt and Playtech, respectively, reflecting positive outlooks for these stocks.
11:00 24.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.